Therefore, modulating the degradational activity of ubiquitin proteasome system mediated by PA28α and PA28β proteins offers a suitable candidate for the development of future treatments for microvascular complications of diabetes particularly in the retina and kidney. Here, PSME2 is linked to diabetes mellitus.